出典:Wikipedia
出典:『Wikipedia』 (2011/07/26 02:57 UTC 版)
Brivaracetam, the 4-n-propyl analog of levetiracetam, is a racetam derivative with anticonvulsant properties. Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle protein SV2. Phase II clinical trials in adult patients with refractory partial seizures were promising. The drug is currently undergoing Phase III clinical trials.